Adjunctive dexamethasone in HIV-associated cryptococcal meningitis

New England Journal of Medicine

Volumn 374, Issue 6, 2016, Pages 543-554

  Beardsley, J ^a,e   Wolbers, M ^a,e   Kibengo, F M ^h   Ggayi, A B M ^h   Kamali, A ^h   Cuc, N T K ^b   Binh, T Q ^c   Chau, N V V ^b   Farrar, J ^a,e   Merson, L ^a,e   Phuong, L ^c   Thwaites, G ^a,e   Van Kinh, N ^b   Thuy, P T ^d   Chierakul, W ⁱ   Siriboon, S ^j   Thiansukhon, E ^k   Onsanit, S ^k   Supphamongkholchaikul, W ^j   Chan, A K ^l,n   Heyderman, R ^f,m   Mwinjiwa, E ^l   Van Oosterhout, J J ^l,m   Imran, D ^o   Basri, H ^a   Mayxay, M ^e,p,q   Dance, D ^e,p   Phimmasone, P ^p   Rattanavong, S ^p   Lalloo, D G ^g,m   Day, J N ^a,e   more..

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c CHO RAY HOSPITAL   (Viet Nam)

^d BACH MAI HOSPITAL   (Viet Nam)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^h MRC   (Uganda)

ⁱ MAHIDOL UNIVERSITY   (Thailand)

^j Ubon Sappasithiprasong Hospital   (Thailand)

^k Udon Thani Center Hospital   (Thailand)

^l DIGNITAS INTERNATIONAL   (Malawi)

^m UNIVERSITY OF MALAWI   (Malawi)

ⁿ UNIVERSITY OF TORONTO   (Canada)

^o CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

^p MAHOSOT HOSPITAL   (Laos)

^q UNIVERSITY OF HEALTH SCIENCES   (Laos)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMPHOTERICIN B DEOXYCHOLATE; ANTIRETROVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; COTRIMOXAZOLE; DEXAMETHASONE; FLUCONAZOLE; PLACEBO; GLUCOCORTICOID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BREAST DISEASE; CEREBROSPINAL FLUID; CONTROLLED STUDY; CRYPTOCOCCAL MENINGITIS; DOUBLE BLIND PROCEDURE; DRUG SAFETY; ENDOCRINE DISEASE; FEMALE; GASTROINTESTINAL DISEASE; HEART DISEASE; HEMATOLOGIC DISEASE; HEPATOBILIARY DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; HYPERNATREMIA; HYPOGLYCEMIA; HYPOKALEMIA; HYPONATREMIA; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOPATHOLOGY; INDONESIA; INFECTION; INFESTATION; INTOXICATION; KIDNEY DISEASE; LAOS; LEUKEMIA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALAWI; MALE; MENTAL DISEASE; METABOLIC DISORDER; MORTALITY RATE; NEUTROPENIA; NUTRITIONAL DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SIDE EFFECT; SKIN DISEASE; THAILAND; THORAX DISEASE; THROMBOCYTOPENIA; TREATMENT DURATION; UGANDA; VASCULAR DISEASE; VIET NAM; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BACTERIAL COUNT; CEREBROSPINAL FLUID PRESSURE; CLINICAL TRIAL; CRYPTOCOCCUS NEOFORMANS; ISOLATION AND PURIFICATION; KAPLAN MEIER METHOD; MENINGITIS, CRYPTOCOCCAL; MICROBIOLOGY; MORTALITY; MULTICENTER STUDY; TREATMENT FAILURE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID PRESSURE; COLONY COUNT, MICROBIAL; CRYPTOCOCCUS NEOFORMANS; DEXAMETHASONE; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MENINGITIS, CRYPTOCOCCAL; TREATMENT FAILURE;

EID: 84959300520     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1509024     Document Type: Article

References (29)

1. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009; 23: 525-30.
2. van der Horst CM, Saag MS, Cloud GA, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med 1997; 337: 15-21.
3. Day JN, Chau TTH, Wolbers M, et al. Combination antifungal therapy for cryptococcal meningitis. N Engl J Med 2013; 368: 1291-302.
4. de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002; 347: 1549-56.
5. Nguyen THM, Tran THC, Thwaites G, et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N Engl J Med 2007; 357: 2431-40.
6. Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004; 351: 1741-51.
7. Casadevall A, Perfect JJR. Cryptococcus neoformans. Washington, DC: American Society for Microbiology, 1998.
8. Scarborough M, Gordon SB, Whitty CJM, et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med 2007; 357: 2441-50.
9. Seaton RA, Verma N, Naraqi S, Wembri JP, Warrell DA. The effect of corticosteroids on visual loss in Cryptococcus neoformans var. gattii meningitis. Trans R Soc Trop Med Hyg 1997; 91: 50-2.
10. Ostrosky-Zeichner L, Soto-Hernandez JL, Angeles-Morales V, et al. Effects of pentoxifylline or dexamethasone in combination with amphotericin B in experimental murine cerebral cryptococcosis: evidence of neuroexcitatory pathogenic mechanisms. Antimicrob Agents Chemother 1996; 40: 1194-7.
11. Lortholary O, Nicolas M, Soreda S, et al. Fluconazole, with or without dexamethasone for experimental cryptococcosis: impact of treatment timing. J Antimicrob Chemother 1999; 43: 817-24.
12. Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2010; 50: 291-322.
13. Day J, Imran D, Ganiem AR, et al. CryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial. Trials 2014; 15: 441.
14. Brouwer AE, Rajanuwong A, Chierakul W, et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet 2004; 363: 1764-7.
15. Boulware DR, Meya DB, Muzoora C, et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. N Engl J Med 2014; 370: 2487-98.
16. The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. MedDRA (http://www.meddra.org).
17. R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2014 (http://www.r-project.org).
18. Sungkanuparph S, Filler SG, Chetchotisakd P, et al. Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study. Clin Infect Dis 2009; 49: 931-4.
19. Haddow LJ, Colebunders R, Meintjes G, et al. Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis 2010; 10: 791-802.
20. Lortholary O, Fontanet A, Mémain N, Martin A, Sitbon K, Dromer F. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIVassociated cryptococcosis in France. AIDS 2005; 19: 1043-9.
21. Török ME, Yen NTB, Chau TTH, et al. Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)-associated tuberculous meningitis. Clin Infect Dis 2011; 52: 1374-83.
22. Heemskerk D, Day J, Chau TTH, et al. Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial. Trials 2011; 12: 25.
23. Bicanic T, Muzoora C, Brouwer AE, et al. Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients. Clin Infect Dis 2009; 49: 702-9.
24. Jarvis JN, Meintjes G, Rebe K, et al. Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial. AIDS 2012; 26: 1105-13.
25. Jarvis JN, Meintjes G, Bicanic T, et al. Cerebrospinal fluid cytokine profiles predict risk of early mortality and immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis. PLoS Pathog 2015; 11(4): e1004754.
26. Elenkov IJ. Glucocorticoids and the Th1/Th2 balance. Ann N Y Acad Sci 2004; 1024: 138-46.
27. Simmons CP, Thwaites GE, Quyen NTH, et al. The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses. J Immunol 2005; 175: 579-90.
28. Loyse A, Thangaraj H, Easterbrook P, et al. Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries. Lancet Infect Dis 2013; 13: 629-37.
29. Loyse A, Dromer F, Day J, Lortholary O, Harrison TS. Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal. J Antimicrob Chemother 2013; 68: 2435-44.